Mark Bagnall is listed as a director on 3 SEC Form D filings by 1 issuer between Dec 2015 and Dec 2016: XCR Diagnostics Inc (Salt Lake City, UT — biotechnology — 2015–2016; $2.5M reported sold to 20 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Ann Marie Buoscio (3 shared filings), Brian Caplin (3 shared filings), Linda Merrill (3 shared filings), Mark Powelson (3 shared filings) and William C Olson (2 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Mark Bagnall and found 6 differences, 1 worth asking the sponsor about: 45% of the money raised went to insiders; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.